Valo Health and Novo Nordisk to Develop Novel Treatments for Cardiometabolic Diseases
The expanded collaboration will continue to leverage the capabilities of Valo’s Opal Computational Platform, as well as key joint capabilities in human data and genetics with Novo Nordisk’s expertise in cardiometabolic diseases.
Novo Nordisk | 09/01/2025 | By Aishwarya
Photys Therapeutics and with Novo Nordisk to Develop Induced Proximity PHICS Technology
Under the terms of the agreement, Photys is eligible to receive up to USD 186 million in upfront, development and commercial milestone payments, in addition to R&D funding and tiered royalty payments on commercial sales.
Novo Nordisk | 23/12/2024 | By Aishwarya
Flagship Pioneering and Metaphore Enter into Research Collaboration with Novo Nordisk
Metaphore Biotechnologies, in partnership with Flagship Pioneering, has inked a research collaboration with Novo Nordisk to develop up to two next-generation therapeutics for obesity management.
Novo Nordisk | 10/05/2024 | By Aishwarya | 177
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy